Почетна › Затајење срца › Arizona
Kliničke studije za Затајење срца u državi Arizona
29 studija za Затајење срца traži učesnike na lokacijama u državi Arizona.
Gradovi u državi Arizona
Zvanični tekst studije (na engleskom)
Left vs Left Randomized Clinical Trial
- Mercy Gilbert & Chandler Regional Medical Centers, Gilbert AZ, Gilbert
- University of Arizona College of Medicine- Phoenix, Tucson
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05650658A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Banner - University Medical Center Tucson, Tucson
Тражи се учесник
Узраст од 18 до 85 · Оба пола · Ажурирано 10. 11. 2026. · NCT07214376Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Chandler
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 4. 11. 2026. · NCT00271180Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Mayo Clinic Phoenix, Phoenix
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07069738ELEVATE-HFpEF Clinical Study
- Banner - University Medical Center Phoenix, Phoenix
Тражи се учесник
Узраст 40 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06678841Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Medical Advancement Centers of Arizona, Phoenix
- Pima Heart and Vascular Clinical Research, Tucson
- Yuma Clinical Trials, Yuma
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459CCM OPEN HF Registry
- Cardiovascular Associates of Mesa, Mesa
- University of Arizona and Banner University Medical Center Phoenix, Phoenix
- HonorHealth Research Institute, Phoenix
- и још 1
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT07112924Assessment of CCM in HF With Higher Ejection Fraction
- CardioVascular Associates of Mesa, Mesa
- Southwest Cardiovascular Associates, Mesa
- HonorHealth, Scottsdale
- и још 1
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT05064709Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Gilbert
- Research Site, Tempe
- Research Site, Tempe
- и још 1
Тражи се учесникФаза 3
Узраст 40 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06677060The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
- CardioVascular Associates of Mesa (CVAM), Mesa
- Honor Health, Scottsdale
Тражи се учесникОпсервациона студија
Узраст 22 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07098858Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Phoenix
- Research Site, Phoenix
Тражи се учесникФаза 3
Узраст од 18 до 130 · Оба пола · Ажурирано 13. 10. 2026. · NCT06307652A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- TMC Hlthcr Clin Res Office, Tucson
- Pima Heart and Vascular, Tucson
Тражи се учесникФаза 2
Узраст од 40 до 84 · Оба пола · Ажурирано 5. 10. 2026. · NCT06979362A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Gilbert
- Research Site, Sun City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07761117BiVACOR® Total Artificial Heart Early Feasibility Study
- Banner - University Medical Center Phoenix, Phoenix
Тражи се учесник
Узраст од 18 до 70 · Оба пола · Ажурирано 28. 9. 2026. · NCT06174103A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- Phoenix, AZ Investigative Site CON-10115, Phoenix
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Glendale, AZ Investigative Site 10096, Glendale
- Phoenix, AZ Investigative Site 10115, Phoenix
- Scottsdale, AZ Investigative Site 10003, Scottsdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT06008197AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- University of Arizona Sarver Heart Center, Tucson
Тражи се учесникФаза 2
Узраст од 40 до 85 · Оба пола · Ажурирано 27. 8. 2026. · NCT06793371Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Banner--University Medical Center Phoenix, Phoenix
- Mayo Clinic - Arizona, Phoenix
Тражи се учесник
Узраст 21 и старији · Оба пола · Ажурирано 25. 8. 2026. · NCT05677100A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Pima Heart and Vascular, Tucson
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Mercy Gilbert Medical Center, Gilbert
- Sun City Clinical Research, Glendale
- Honor Health, Phoenix
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07567001Alleviant ALLAY-HF Study
- Pima Heart and Vascular, Tucson
Тражи се учесник
Узраст 40 и старији · Оба пола · Ажурирано 14. 8. 2026. · NCT05685303A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- Phoenix, AZ Investigative Site FIN-10115, Phoenix
- FIN-10401, Yuma, AZ, Yuma
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 7. 2026. · NCT06033950PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- St. Joseph's Hospital and Medical Center, Phoenix
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 29. 6. 2026. · NCT05934487Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
- Peak Heart and Vascular, Avondale
- Banner Medical Center, Mesa
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 5. 5. 2026. · NCT06641362The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers, Gilbert
- Banner Health - Phoenix, Phoenix
- Tucson Medical Center Health, Tucson
- и још 1
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT03142152Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
- Gilbert Cardiology, Gilbert
- Arizona Heart Foundation, Phoenix
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 12. 2. 2026. · NCT07403669His-Bundle Corrective Pacing in Heart Failure
- University of Arizona, Phoenix
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 9. 2. 2026. · NCT05265520Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- HonorHealth, Scottsdale
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2025. · NCT06964464Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
- Multiple Locations, Phoenix
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 20. 3. 2024. · NCT04905160Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.